Culture supernatant of stem cells derived from dental pulp for the improvement of myopia, astigmatism, presbyopia, eye fatigue, or blurred vision
Patent Information
- Application Number
- DE602022016223
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-06-21
- Filing Date
- 2022-02-01
- Publication Date
- 2025-06-18
- Estimated Expiration
- 2042-02-01
AI Technical Summary
There is a growing need for effective agents to improve ocular symptoms such as myopia, astigmatism, presbyopia, eye fatigue, and blurred vision, which are increasingly prevalent due to factors like prolonged screen time and aging.
A culture supernatant of dental pulp-derived stem cells or immortalized stem cells thereof is used as a composition to improve ocular symptoms. This supernatant contains bioactive substances that can enhance visual function and alleviate symptoms of myopia, astigmatism, presbyopia, eye fatigue, and blurred vision.
The use of the culture supernatant of dental pulp-derived stem cells has been shown to significantly improve uncorrected and corrected eyesight, astigmatism grades, and presbyopia, providing temporary correction and relief from ocular symptoms.